COVID-19 is Hurting Chronic Migraine Care in Canada

Brandon Plaizier News

June is National Migraine and Headache Awareness Month TORONTO, June 23, 2020 /CNW/ – Like most chronic conditions, COVID-19 is having an incredible impact on patients living with chronic migraines (CM). Allergan, an AbbVie Company, …

Breaking News on Coverage of Mifegymiso

Admin News

A medical abortion drug, Mifegymiso, is now available to all women in the province at no cost to them. Alberta is the second province in Canada to introduce universal coverage for Mifegymiso.